Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus

Nature Biotechnology

Volumn 15, Issue 6, 1997, Pages 547-551

  Agadjanyan, Michael ^a   Luo, Ping ^a   Westerink, M A Julie ^a,b   Carey, Lisa A ^a   Hutchins, Wendy ^a,b   Steplewski, Zenon ^a,c   Weiner, David B ^a   Kieber Emmons, Thomas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Applied immunology; Carbohydrate; HIV 1; Lewis Y; Peptide mimetic; Polysaccharide

Indexed keywords

CARBOHYDRATE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS NEUTRALIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CARBOHYDRATES; CELL LINE; EPITOPES; H-2 ANTIGENS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV-1; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTRALIZATION TESTS; OLIGOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030951314     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0697-547     Document Type: Article

References (33)

1. Robinson, W.J., Montefiori, D.C., and Mitchell, W.M. 1987. Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis. AIDS Res. Hum. Retroviruses 3:265-282.
2. Bolmstedt, A., Olofsson, S., Sjogren, J.E., Jeansson, S., Sjoblom, I., Akerblom, L., et al. 1992. Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J. Gen. Virol. 73:3099-3105.
3. Gattegno, L., Ramdani, A., Jouault, T., Saffar, L., and Gluckman, J.C. 1992. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). AIDS Res. Hum. Retroviruses 8:27-37.
4. Muller, W.E., Bachmann, M., Weiler, B.E., Schroder, H.C., Uhlenbruck, G., Shinoda, T., et al. 1991. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. J. Acquired Immune Deficiency Syndromes 4:694-703.
5. Hansen, J.E., Nielsen, C., Arendrup, M., Olofsson, S., Mathiesen, L., Nielsen, J.O. et al. 1991. Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus. J. Virol. 65:6461-6467.
6. Furukawa, K., Akagi, T., Nagata, Y., Yamada, Y., Shimotohno, K., Cheung, N.K., et al. 1993. GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyl-transferase gene by p40tax. Proc. Natl. Acad. Sci. USA 90:1972-1976.
7. Mond, J.J., Lees, A., and Snapper, C.M. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
8. Kitamura, K., Stockert, E., Garin, C.P., Welt, S., Lloyd, K.O., Armour, K.L., et al. 1994. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generated against synthetic and natural Le(y) determinants. Proc. Natl. Acad. Sci. USA 91:12957-12961.
9. Adluri, S., Helling, F., Ogata, S., Zhang, S., Itzkowitz, S.H., Lloyd, K.O., et al. 1995. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol. Immunother. 41:185-192.
10. Westerink, M.A.J., Giardina, P.C., Apicella, M.A., and Kieber-Emmons, T. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:4021-4025.
11. Sugiyama, T., Imai, K., Ono, A., Takayama, Y., Tsujisaki, M., Taki, T., et al. 1991. Conformational structure of a monoclonal anti-idiotypic antibody to the monoclonal anti-adenocarcinoma-associated carbohydrate antibody YH206. J. Immunol. 146:3097-1301.
12. Diakun, K.R. and Matta, K.L. 1989. Synthetic antigens as immunogens: part III. Specificity analysis of an anti-anti-idiotypic antibody to a carbohydrate tumor-associated antigen. J. Immunol. 142:2037-2040.
13. Shikhman, A.R. and Cunningham, M.W. 1994. Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response. J. Immunol. 152:4375-4387.
14. Tsuyuoka, K., Yago, K., Hirashima, K., Ando, S., Hanai, N., Saito, H., et al. 1996. Characterization of a T cell line specific to an anti-Id antibody related to the carbohydrate antigen, sialyl SSEA-1, and the immundominant T cell antigenic site of the antibody. J. Immunol. 157:661-669.
15. Hutchins, W., Adkins, A., Kieber-Emmons, T., and Westerink, M.A.J. 1996. Molecular characterization of a monoclonal antibody produced in response to a group-C Meningococcal polysaccharide peptide mimic. Mol. Immunol. 33:503-510.
16. Imberty, A. and Perez, S. 1994. Molecular modelling of protein-carbohydrate interactions. Understanding the specificities of two legume lectins towards oligosaccharides. Glycobiology 4:351-366.
17. Oldenburg, K.R., Loganathan, D., Goldstein, I.J., Schultz, P.G., and Gallop, M.A. 1992. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89:5393-5397.
18. Scott, J.K., Loganathan, D., Easley, R.B., Gong, X., and Goldstein, I.J. 1992. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89:5398-5402.
19. Murai, H., Hara, S., Ikenaka, T., Goto, A., Arai, M., and Murao, S. 1985. Amino acid sequence of protein alpha-amylase inhibitor from Streptomyces griseosporeus YM-25. J. Biochem. 97:1129-1133.
20. Mirkov, T.E., Evans, S.V., Wahistrom, J., Gomez, L., Young, N.M., and Chrispeels, M.J. 1995. Location of the active site of the bean alpha-amylase inhibitor and involvement of a Trp, Arg, Tyr triad. Glycobiology 5:45-50.
21. Hoess, R., Brinkmann, U., Handel, T., and Pastan, I. 1993. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128:43-49.
22. Steplewski, Z., Blaszczyk, T.M., Lubeck, M., Loibner, H., Scholz, D., and Koprowski, H. 1990. Oligosaccharide Y specific monoclonal antibody and its isotype switch variants. Hybridoma 9:201-210.
23. Thurin-Blaszczyk, M., Murali, R., Westerink, M.A.J., Steplewski, Z., Co, M.-S., and Kieber-Emmons, T. 1996. Molecular recognition of the Lewis Y antigen by monoclonal antibodies. Protein Eng. 9:101-113.
24. Prammer, K.V., Boyer, J., Ugen, K., Shattil, S.J., and Kieber-Emmons, T. 1994. Bioactive Arg-Gly-Asp conformations in anti-integrin GPiib-iiia antibodies. Receptor 4:93-108.
25. Agadjanyan, M.G., Ugen, K.E., Wang, B., Willlams, W.V., and Weiner, D.B. 1994. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection. J. Virol. 68:485-493.
26. Ugen, K.E., Rafaell, Y., Fiegner, U., Agadjanyan, M.G., Satre, M., Srikantan, V., et al. 1993. Generation of monoclonal antibodies against the amino region of GP120 which elicits antibody dependent cellular cytotoxicity. Modern approaches to new vaccines including prevention of AIDS. pp. 215-221 in Vaccines. Cold Spring Harbor Press, Cold Spring Harbor, NY.
27. Willey, R.L., Shibata, R., Freed, E.O., Cho, M.W., and Martin, M.A. 1996. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol. 70:6431-6436.
28. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
29. Moore, J.P., Cao, Y., Qing, L., Sattentau, Q.J., Pyati, J., Koduri, R., et al. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
30. Gram, G.J., Hemming, A., Bolmstedt, A., Jansson, B., Olofsson, S., Akerblom, L., et al. 1994. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch. Virol. 139:253-261.
31. Earl, P.L., Broder, C.C., Long, D., Lee, S.A., Peterson, J., Chakrabarti, S., et al. 1994. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:3015-3026.
32. Montefiori, D.C., Robinson, W.J., Schuffman, S.S., and Mitchell, W.M. 1988. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. J. Clin. Microbiol. 26:231-235.
33. Nara, P.L. and Fischinger, P.J. 1988. Quantitative infectivity assay for HIV-1 and -2. Nature 332:469-470.